There are an estimated 785,000 new heart attack cases in the United States each year, with no gold standard treatment for repairing the resulting damage to cardiac tissue. There has been much interest in using regenerative medicine to treat heart attack sufferers, with the vast majority of trials involving stem cells. However, tissues also include a scaffolding framework, the extracellular